<html>  <!--	Author: 	Dr. Johan T. den Dunnen	Date: 	17-11-2002		URL: 	recs.html-->  <head>    <meta content="text/html; charset=windows-1252" http-equiv="content-type">    <title>HGVS recommendations: nomenclature for the description of sequence      variants</title>    <style type="text/css"><!--  h2 { font-family : Verdana,Arial,Helvetica,Geneva,sans-serif; color : #ff9900;}h3 { font-family : Verdana,Arial,Helvetica,Geneva,sans-serif; color : #0099cc;}h4 { font-family : Verdana,Arial,Helvetica,Geneva,sans-serif; color : #0099cc;}h5 {font-family : Verdana, Arial, Helvetica, Geneva, sans-serif;color : #ffffff;}.norm { font-weight : normal; } --></style> </head>  <body style=" color: black; background-color: white;" link="#0000FF" vlink="#9999ff">    <table bgcolor="#CCFF99" border="0" cellpadding="10" cellspacing="0" width="100%">      <tbody>        <tr>          <td bgcolor="#FFFFFF" valign="top" width="25%"><a href="http://www.HGVS.org"><img                src="small.gif"                border="0"                height="94"                width="155"></a></td>          <td bordercolor="#FFFFFF" bgcolor="#FFFFFF" valign="CENTER" width="75%">            <h3 align="center">Recommendations for the description of sequence              variants </h3>          </td>        </tr>      </tbody>    </table>    <table border="0" cellpadding="10" cellspacing="0" width="100%">      <tbody>        <tr>          <td bgcolor="#0099cc" valign="BOTTOM" width="100%">            <h4 align="center"><font color="#FFFFFF" size="3"><i><br>                  Last modified January 10, 2016</i></font></h4>          </td>        </tr>      </tbody>    </table>    <p align="center"><i><font face="Times New Roman">Since references to          WWW-sites are not yet acknowledged as citations, please mention <a href="http://www3.interscience.wiley.com/cgi-bin/fulltext/68503056/PDFSTART">den
            Dunnen JT and Antonarakis SE (2000). Hum.Mutat. 15:7-12</a> when          referring to these pages.</font></i></p>    <hr>    <h2>Contents</h2>    <ul>      <li><a href="#intro"><b>Introduction</b></a></li>      <li><b>Recommendations</b>        <ul>          <li><a href="#general">general</a></li>          <li><a href="recs-DNA.html">DNA level</a></li>          <li><a href="recs-RNA.html">RNA level</a></li>          <li><a href="recs-prot.html">protein level</a></li>        </ul>      </li>      <li><b>Explanations / examples</b>        <ul>          <li><a href="quickref.html">Quick Reference</a></li>          <li><a href="examplesDNA.html">changes at DNA-level</a></li>          <li><a href="examplesRNA.html">changes at RNA-level</a></li>          <li><a href="examplesAA.html">changes at protein-level</a></li>        </ul>      </li>    </ul>    <hr>    <h2><a name="intro"></a>Introduction</h2>    <hr>    <p>Discussions regarding the uniform and unequivocal description of sequence      variants in DNA and protein sequences (mutations, polymorphisms) were      initiated by two papers published in 1993; Beaudet AL &amp; Tsui LC (<a href="http://onlinelibrary.wiley.com/doi/10.1002/humu.1380020402/abstract">DOI
        paper</a> / <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8401532&amp;dopt=Abstract">abstract</a>)      and Beutler E (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1682427/pdf/ajhg00054-0240.pdf">paper</a>      / <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8352285&amp;dopt=Abstract">abstract</a>).
      The original suggestions presented were widely discussed, modified,      extended and ultimately resulted in nomenclature recommendations that have      been largely accepted and are applied world-wide (<a href="history.html"><i>see
          History</i></a>).</p>    <p>Current rules (den Dunnen, JT and Antonarakis, SE (2000), <a href="http://www3.interscience.wiley.com/cgi-bin/fulltext/68503056/PDFSTART">paper
        </a>/ <a href="http://www.ncbi.nlm.nih.gov/pubmed/10612815">abstract</a>)      however do not extensively cover all types of variants and the more      complex changes. These pages will list, based on the last publication, the      existing nomenclature recommendations as well as the most recent      suggestions (<i>in italics and marked <a href="#del"><img src="new.gif" border="0"            height="12"            width="31"></a></i>).
More
      details regarding the&nbsp; latest additions can be found at the <a href="disc.html"><i>Discussion
          page</i></a>.&nbsp;These pages can be used as a guide to describe any      sequence variant identified and should help to get a uniformly accepted      standard.</p>    <p>Discussions regarding the advantages and disadvantages of the      recommendations made are necessary in order to continuously improve the      system. What is listed on these pages represents the current consensus of      the discussions. We invite investigators to communicate to us regarding      the recommendations as well as to send us complicated cases not yet      covered, with a suggestion of how to describe these (E-mail to: <a href="mailto:VarNomen%20@%20HGVS.org">VarNomen
        @ HGVS.org</a>).&nbsp;<br>    </p>    <h3>Mutation and polymorphism</h3>    <p>In some disciplines the term<b><i> </i>"mutation"</b> is used to      indicate "<em>a change</em>" while in other disciplines it is used to      indicate "<em>a disease-causing change</em>". Similarly, the term <b>"polymorphism"
        </b>is used both to indicate "<em>a non disease-causing change</em>" or      "<em>a change found at a frequency of 1% or higher in the population</em>".
      To prevent this confusion we do not use the terms mutation and      polymorphism (including SNP or Single Nucleotide Polymorphism) but use      neutral terms like <strong>"sequence variant"</strong>, <strong>"alteration"
        </strong>and <strong>"allelic variant"</strong>. The Vol.19(1) issue of      Human Mutation (2002) contains several contributions discussing these      issues as well as the fact that the term <b>"mutation"</b> has developed      a negative connotation (see <a href="http://onlinelibrary.wiley.com/doi/10.1002/humu.10029/pdf">Cotton
RGH
        - p.2</a>, <a href="onlinelibrary.wiley.com/doi/10.1002/humu.10023/pdf">Condit
CM
        et al. - p.69</a> and <a href="onlinelibrary.wiley.com/doi/10.1002/humu.10021/pdf">Marshall
JH
        - p.76</a>). Therefore, current guidelines of authorative organisations      now also recommend to use the neutral term "<span style="font-weight: bold;">variant</span>"      only (e.g.&nbsp;<a href="http://www.nature.com/gim/journal/v17/n5/pdf/gim201530a.pdf">Richards
        2015, Genet.Med. 17:405-424</a>).<br>    </p>    <h3><img src="new.gif" border="0" height="12" width="31">Pathogenic</h3>    <p>Another confusing term used frequently is "a <strong>pathogenic</strong>      variant". While a non-expert concludes the variant described "<em>causes        disease</em>", the expert probably means "<em>causes disease when in a        specific context</em>" </p>    <ul>      <li>causes disease when found in a male (X-linked recessive disorder)</li>      <li>causes disease when combined with a similar chance in the other allele        (autosomal recessive)</li>      <li>causes disease when inherited from the father (imprinted)</li>    </ul>    <p>To prevent confusion it therefore seems best not to use the term "<em>pathogenic</em>".
A
      good alternative seems a neutral term like "<strong>affects function</strong>".
In
      fact this properly describes what one actually means, the variant affects      the normal function of the gene/protein (in whatever way). This also      solves the issue of what term to use for non-disease phenotypes like      skin/hair/eye colour or blood group. In such cases it is problematic to      choose the phenotype to call "<em>norma</em>l" or "<em>pathogenic</em>".      Using "<strong>affects function</strong>" is clear and effective. To      classify variants people use most frequently 5 categories. Based on      affects function these could be; <em>affects funtcion,&nbsp; probably        affects function,&nbsp; unknown,&nbsp; probably does not affect function        (or probably no functional effect),&nbsp; does not affect function (no        functional effect)</em>. Variants for which a functional effect is      unknown can together be called "<strong>variants of unknown significance</strong>"      (<strong>VUS</strong>).</p>    <hr>    <h2><a name="general"></a>General recommendations</h2>    <p><em>(suggestions extending the <a href="http://www3.interscience.wiley.com/cgi-bin/fulltext/68503056/PDFSTART">published</a>        recommendations in italics)</em></p>    <hr>    <p><a name="version"></a>The most important rule is that all variants should      be described at the most basic level, i.e. the DNA level. Descriptions      should always be in relation to a <b>reference sequence</b>, either a <b>genomic</b>      or a <b>coding DNA</b> reference sequence. Discussions on which type of      reference sequence to prefer, genomic or coding DNA, have been lively.      Although theoretically a genomic reference sequence seems best, in      practice a coding DNA reference sequence is preferred (see <a href="refseq.html"><i>Reference
Sequence
          discussions</i></a>). </p>    <ul>      <li><i><b>describing genes / proteins, only official <a href="http://www.genenames.org/guidelines.html">HGNC
              gene symbols</a> should be used</b></i></li>      <li>all changes reported <span style="font-style: italic; font-weight: bold;">must
          be described at DNA-level</span>. When descriptions at RNA or protein        level are given in the text (including TITLE and ABSTRACT), on first        mention, a format like "c.78G&gt;T (r.78g&gt;u, p.Trp26Cys)" should be        used. </li>      <li>when several changes are described in one manuscript, a tabular        listings should be provided summarizing the findings, using separate        columns for DNA, RNA and protein, clearly indicating whether the changes        were <strong style="font-style: italic;">experimentally determined</strong>        or only <b style="font-style: italic;">theoretically deduced</b>        (predicted). When changes in patients with a recessive disease are        described, the listing should make clear in which combination the        changes were found. An additional column can be used to mention        additional findings and to make remarks.</li>      <li><a name="prefix"></a>to avoid confusion in the description of a        variant it should be preceded by a letter indicating the type of        reference sequence used. The reference sequence used must contain the        residue(s) described to be changed. Possible reference sequence types (<i><a            href="figure_refseq.html">see
            Figure</a></i>);        <ul>          <li>"c." for a <strong>coding DNA</strong> sequence (like&nbsp;            c.76A&gt;T)</li>          <li>"g." for a <strong>genomic</strong> sequence (like g.476A&gt;T)</li>          <li>"m." for a <strong>mitochondrial</strong> sequence (like            m.8993T&gt;C, <i><a href="refseq.html#mtDNA">see Reference Sequence</a></i>)          </li>          <li><i><img src="new.gif" border="0" height="12" width="31"></i>"n"            for a <strong>non-coding RNA</strong> reference sequence (gene            producing an RNA transcript but not a protein<em>, <a href="accepted_002.html">see
                Community consultation 002</a>)</em></li>          <li>"r." for an <strong>RNA</strong> sequence (like r.76a&gt;u)</li>          <li>"p." for a <strong>protein</strong> sequence (like&nbsp;            p.Lys76Asn)</li>        </ul>      </li>      <li><i><img src="new.gif" border="0" height="12" width="31">the DNA          reference sequence used should preferably be a LRG </i>(Locus        Reference Genomic sequence, <a href="refseq.html#general"><i>see            Reference Sequence</i></a>)<span style="font-style: italic;">.<br>          Reporting using LRGs as a reference is possible for genomic DNA (e.g.          LRG_1:g.8463G&gt;C), coding DNA (e.g. LRG_1t1:c.572G&gt;C), non-coding          RNA (e.g. LRG_163t1:n.5C&gt;T) and protein (e.g. LRG_1p1:p.Gly191Ala)          variants. To describe coding DNA/non-coding RNA variants the          transcript must be indicated (e.g. "<span style="font-weight: bold;">t1</span>"),&nbsp;
          for protein variants the protein isoform (e.g. "<span style="font-weight: bold;">p1</span>").</span>        <ul>          <li><a name="indicator"></a>within one document only one DNA reference            sequence should be used. When variants in more than one sequence            (gene) are described, any confusion should be prevented by including            a unique indicator in the description. Indicator and sequence            description should be separated by a colon ("<span style="font-weight: bold;">:</span>")
            like in LRG1_t1:c.3G&gt;T (or, but only when the reference sequence            used was clearly defined elsewhere, COL1A1:c.3G&gt;T).<br>            <i><b>NOTE:</b></i> this format is especially important for            unequivocal descriptions of SNP's (<a href="disc.html#SNP"><i>see                Discussion</i></a>). <a href="#del"><i><img src="new.gif" border="0"                  height="12"                  width="31">When
                both HGNC-approved gene symbol and database accession.version                number are indicated this should be done using the format                NM_004006.1(DMD):c.3G&gt;T&nbsp;</i> (</a><a href="disc.html#indicator"><i>see
                Discussion</i></a>)<i>.</i></li>          <li><i><img src="new.gif" border="0" height="12" width="31">the coding              DNA reference sequence used should represent the major and largest              transcript of the gene. Alternatively spliced exons (5'-first,              internal or 3'-terminal) derived from <b>within the gene</b> can              be numbered as for intronic sequences. Variants in transcripts              initiating or terminating <b>outside this region</b> can be              described as upstream / downstream sequences (<a href="refseq.html">see
                Reference Sequence discussions</a>).&nbsp;</i></li>          <li>protein reference sequences should represent the primary            translation product, not a processed mature protein (<a href="FAQ.html#protref"><i>see
                FAQ</i></a>).</li>          <li><i><img src="new.gif" border="0" height="12" width="31">when              changes start or end in another sequence (gene), e.g. for large              deletions, the nucleotide numbering for that end is based on the              nucleotide numbering of that sequence (like              c.827_NM_004004.3:c.235del). When the endpoint occurs on the              opposite, non-transcribed strand (anti-sense strand), an&nbsp; "o"              precedes the reference identifier (like              c.827_oNM_004004.3:c.233del, <a href="disc.html#fusion">see                Discussion</a>).</i></li>          <li><a name="twogenes"></a><i><img src="new.gif" border="0" height="12"                width="31">when
              a variant affects more then one gene, to prevent confusion, the              variant should be described in relation to all genes              affected.&nbsp;</i></li>        </ul>      </li>      <li>for a clear distinction, descriptions at DNA, RNA and protein level        are unique;        <ul>          <li><u>DNA-level</u><br>            in capitals, starting with a number referring to the first            nucleotide affected (like c.76A&gt;T or g.476A&gt;T)</li>          <li><u>RNA-level</u><br>            in lower-case, starting with a number referring to the first            nucleotide affected (like r.76a&gt;u)</li>          <li><u>protein level</u><br>            in capitals, starting with a letter referring to first the amino            acid affected (like p.Lys76Asn)</li>        </ul>      </li>      <li><a name="ntinumber"></a><b>nucleotide numbering</b>&nbsp; <i>(for          details and examples <a href="refseq.html">see Reference Sequence            discussions</a>)</i>        <ul>          <li><u>coding DNA Reference Sequence</u>&nbsp; (<i><a href="figure_refseq.html">see
                Figure</a> and <a href="standards.html#number">Numbering</a></i>)            <ul>              <li>there is no nucleotide 0</li>              <li>nucleotide 1 is the A of the ATG-translation initiation codon</li>              <li>the nucleotide <b>5' of the ATG-translation initiation</b>                codon is -1, the previous -2, etc.<br>                <i><img src="new.gif" border="0" height="12" width="31"></i><em><strong>NOTE:</strong>                  den Dunnen &amp; Antonarakis (<a href="http://dx.doi.org/10.1002/%28SICI%291098-1004%28200001%2915:1%3c7::AID-HUMU4%3e3.0.CO;2-N">Hum.Mut.
                    15: 7-12</a>) write "For <strong>genomic DNA</strong> and                  cDNA sequences, the A of the ATG of the initiator Methionine                  codon is denoted nucleotide +1". This is an error, correct is;                  "In coding DNA reference sequences, the A of the ATG of the                  initiator Methionine codon is denoted nucleotide +1".</em></li>              <li><i><img src="new.gif" border="0" height="12" width="31">the                  nucleotide <b>3' of the translation stop codon</b> is *1, the                  next *2, etc.</i></li>              <li>intronic nucleotides                <ul>                  <li><u>beginning of the intron;</u> the number of the last                    nucleotide of the preceding exon, a plus sign and the                    position in the intron, like c.77+1G, c.77+2T, etc.</li>                  <li><u>end of the intron;</u> the number of the first                    nucleotide of the following exon, a minus sign and the                    position upstream in the intron, like c.78-1G.</li>                  <li>in the <u>middle of the intron,</u> numbering changes                    from "c.77+.." to "c.78-.."; for introns with an uneven                    number of nucleotides the central nucleotide is the last                    described with a "+" <i>(<a href="refseq.html#IVS">see                        Reference Sequence discussions</a>)</i></li>                </ul>              </li>            </ul>          </li>          <li><u>genomic Reference Sequence</u>&nbsp; (<i><a href="figure_refseq.html">see
                Figure</a></i>)            <ul>              <li>nucleotide numbering is purely arbitrary and starts with 1 at                the first nucleotide of the database reference file<br>                <em><img src="new.gif" border="0" height="12" width="29"><strong>NOTE:</strong>                  in den Dunnen&amp;Antonarakis (<a href="http://dx.doi.org/10.1002/%28SICI%291098-1004%28200001%2915:1%3c7::AID-HUMU4%3e3.0.CO;2-N">Hum.Mut.
                    15: 7-12</a>) write "For <strong>genomic DNA</strong> and                  cDNA sequences, the A of the ATG of the initiator Methionine                  codon is denoted nucleotide +1". This is an error, correct is;                  "In genomic reference sequences, the first nucleotide is                  nucleotide 1".</em></li>              <li>no +, - or other signs are used</li>              <li>the sequence should include all nucleotides covering the                sequence (gene) of interest and should start well 5' of the                promoter of a gene</li>              <li>when the complete genomic sequence is not known, a coding DNA                reference sequence should be used</li>            </ul>          </li>        </ul>      </li>      <li><b>specific changes</b>        <ul>          <li>"&gt;" indicates a <b><i>substitution</i></b> at DNA level            (like&nbsp; c.76A&gt;T)</li>          <li>"_" (underscore) indicates a <i><b>range</b></i> of affected            residues, separating the first and last residue affected (like            c.76_78delACT, <em><a href="disc.html#range">see Discussion</a></em>)</li>          <li>"del" indicates a <i><b>deletion</b></i> (like&nbsp; c.76delA)</li>          <li>"dup" indicates a <i><b>duplication</b></i> (like&nbsp;            c.76dupA); <i><img src="new.gif" border="0" height="12" width="31">duplicating
              insertions are described as <b>duplications</b>, not as              insertions; ACTTTGTGCC to ACTTTGTG<u><b>G</b></u>CC is described              as c.8dupG (not as c.8_9insG, <a href="disc.html#dupins">see                Discussion</a>)</i></li>          <li>"ins" indicates a <i><b>insertion</b></i> (like&nbsp;            c.76_77insG)</li>          <li><i><img src="new.gif" border="0" height="12" width="31"></i>"inv"            indicates an <i><b>inversion</b></i> (like&nbsp; c.76_83inv)</li>          <li><i><img src="new.gif" border="0" height="12" width="31">"con"              indicates a <b>conversion</b>              (like&nbsp;c.123_678conNM_004006.1:c.123_678, <a href="recs-DNA.html#con">see
                Recommendations</a>)</i></li>          <li>"[]" indicates an allele (like&nbsp;c.[76A&gt;T], <a href="#2in1"><i>see
                Recommendations</i></a>)</li>          <li>&nbsp;<a name="uncertain"></a><i><a href="#del"><img src="new.gif"                  border="0"                  height="12"                  width="31"></a>"()"
              is used when the exact position of a change is not known, the              range of the uncertainty is described as precisely as possible and              listed between brackets (like c.(67_70)insG, <a href="uncertain.html">see
                Uncertainties</a>)</i></li>        </ul>      </li>      <li><b>miscellaneous&nbsp;</b>        <ul>          <li><a name="repeat"></a>for all descriptions the <b>most 3' position</b>            possible is arbitrarily assigned to have been changed, this is            important especially in single residue (nucleotide or amino acid)            stretches or tandem repeats (<a href="recs-DNA.html#del"><i>see                Recommendations</i></a>, <i><a href="disc.html#loss">see                Discussion</a></i>)</li>          <li><i>variability in the number of repeated sequences (e.g. ATGCGA<b>TGTGTG</b>CC)
              are described as c.123+74TG(3_6) (<a href="recs-DNA.html#var">see                Recommendations</a>)</i></li>          <li><i><img src="new.gif" border="0" height="12" width="31">triplications,
              quadruplications, etc. are described as alleles of variable short              sequence repeats; c.87_93[3] describes a triplication of the 7              nucleotides from coding DNA position 87 to 93 (not as c.87_93tri,              <a href="recs-DNA.html#tri">see Discussion</a>)</i></li>          <li><a name="2in1"></a><i><b>two sequence variants in one individual</b></i>            <ul>              <li><u>two sequence changes in different alleles</u> (e.g. for                recessive diseases) are listed between square brackets,                separated by a ";"-character; c.[76A&gt;C];[87delG] (<a href="disc.html#2in2"><i>see
                    Discussion</i></a>)</li>              <li><u>two sequence variants in one allele</u> are listed between                square brackets, separated by a ";"-character; c.[76A&gt;C;                83G&gt;C] (<em><a href="disc.html#2in1">see Discussion</a></em>)</li>              <li><i><img src="new.gif" border="0" height="12" width="31"><u>two                    sequence changes with alleles unknown</u> are listed between                  square brackets, separated by "(;)"; c.[76A&gt;C(;)83G&gt;C] (<a                    href="FAQ.html#2unknown">see
                    FAQ</a>)</i></li>              <li><i><img src="new.gif" border="0" height="12" width="31">descriptions
                  of sequence changes in different genes (e.g. for recessive                  diseases) are listed between square brackets, separated by a                  ";"-character and include a reference to the sequence (gene)                  changed; DMD:c.[76A&gt;C];GJB:c.[87delG] (<a href="disc.html#2in2genes">see
                    Discussion</a>)</i></li>            </ul>          </li>          <li><i><img src="new.gif" border="0" height="12" width="31"><u><b>mosaic
                  cases:</b> two different nucleotides at one position in one                allele</u> are listed between square brackets, separated by a              "/"-character; c.[=/83G&gt;C] (<a href="changes.html">see Recent                changes</a>)</i></li>          <li><i><img src="new.gif" border="0" height="12" width="31"><u><b>chimeric
                  cases:</b> two different nucleotides at one position in one                allele</u> are listed between square brackets, separated by a              "//"-character; c.[=//83G&gt;C] (<a href="changes.html">see Recent                changes</a>)</i></li>        </ul>      </li>      <li>a unique identifier should be assigned to each variant; when        available, the OMIM-identifier can be used, otherwise database curators        should assign a unique identifier.</li>    </ul>    <h3>Detailed recommendations</h3>    <ul>      <li><a href="recs-DNA.html">DNA level</a> </li>      <li><a href="recs-RNA.html">RNA level</a> </li>      <li><a href="recs-prot.html">protein level</a> </li>    </ul>    <hr>    <p align="center">| <a href="#top">Top of page</a> | <a href="index.html">Homepage</a>      | <a href="checklist.html">Check-list</a> | <a href="standards.html">Symbols,
        codons, etc.</a> |<br>      | <b>Recommendations:</b>&nbsp; <a href="recs.html">general</a>,&nbsp;<a        href="recs-DNA.html">DNA</a>,&nbsp;
      <a href="recs-RNA.html">RNA</a>,&nbsp; <a href="recs-prot.html">protein</a>,      <a href="uncertain.html">uncertain</a> |<br>      | <a href="disc.html">Discussions</a> | <a href="FAQ.html">FAQ's</a> | <a        href="history.html">History</a>      |<br>      | <b>Example descriptions:&nbsp;</b> <a href="quickref.html">QuickRef</a>,&nbsp;
      <a href="examplesDNA.html">DNA</a>,&nbsp; <a href="examplesRNA.html">RNA</a>,&nbsp;
      <a href="examplesAA.html">protein</a> | </p>    <table bgcolor="#ff9900" border="0" cellpadding="15" cellspacing="0" width="100%">      <tbody>        <tr>          <td>            <p align="center"><font color="#FFFFFF" face="Verdana, Arial, Helvetica, sans-serif"                size="-5"><a                  href="http://www.HGVS.org/copyright.html">Copyright
                  ©</a> </font><font size="1">HGVS 2010 All Rights Reserved<br>                Website Created by Rania Horaitis, Nomenclature by J.T. Den                Dunnen - <a href="http://www.HGVS.org/disclaimer.html">Disclaimer</a>              </font></p>          </td>        </tr>      </tbody>    </table>  </body></html>